Delivery Order HHSN271201700015I-75N95020F00002
- This is a $2,743,201.00 Cost Plus Fixed Fee contract awarded by the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences to Battelle Memorial Institute, a non-profit research and development organization, for non-clinical safety assessment of VK4-116 to support human patients with severe pain disorders. The contract is a delivery order under Battelle's CRO Support for NCATS In Vitro and In Vivo Toxicology Studies master IDIQ...
- The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $4,288 delivery order to Battelle Memorial Institute under the Center's master IDIQ contract for CRO Support for in vitro and in vivo toxicology studies. Under the order, Battelle will perform non-clinical safety assessment of CTI-1601 to support an ataxia indication as requested by the Center. The work will be conducted in Columbus, Ohio over an 18-month period concluding in March 2019. Funding...
- This is a delivery order issued under the "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" IDIQ contract by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The $634,385.25 award to Battelle Memorial Institute, a non-profit research and development organization, is for a 13-hour cardiovascular and pulmonary safety pharmacology study of the drug candidate HBN-1 using telemetered...
- This is a cost-plus-fixed-fee delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $464,908.00 contract is for non-clinical safety assessment of the drug candidate NES100 to support its development for an analgesia (pain relief) indication. The period of performance is from September 17, 2020 to March 16, 2021. This delivery order...
- This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) to Battelle Memorial Institute, doing business as Battelle. The contract, which has a period of performance from September 17, 2020 to January 16, 2021, is for non-clinical safety studies of the compound DIPMA-AP to support its development for a chronic pain indication. The potential value of the...
- This is a $14,106,772 cost plus fixed fee delivery order awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Battelle Memorial Institute for validation of bioanalytical assays and IND-enabling GLP PD/PK toxicology studies in rats and dogs. The work is being performed under the Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders indefinite delivery, indefinite quantity...
- This is a federal contract award to Battelle Memorial Institute (doing business as Battelle), a non-profit research and development organization, by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS). The contract, valued at $460,936.39, is for non-clinical safety assessment of the compound JM-4 to support multiple sclerosis and traumatic brain injury indications. The contract is a delivery order...
- This is a delivery order worth $3,102 awarded by the National Cancer Institute (NCI) to Battelle Memorial Institute, a nonprofit research and development organization, for a contract orientation meeting related to preclinical pharmacology and toxicology studies. The delivery order was issued under a larger Preclinical Pharmacology and Toxicology Studies contract vehicle that runs from 2012 to 2014. The award does not have a set-aside designation. Battelle frequently partners with universities...
- This is a $2,495,455.00 delivery order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the IIT Research Institute (IITRI), a non-profit contract research organization and division of the Illinois Institute of Technology. The contract is for non-clinical safety assessment of a covalent bi-tox compound to support a neuropathic pain indication. This delivery order is part of a larger $48.6 million multiple-award CRO Support for NCATS In Vitro and...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a $1,027,022.00 cost-plus-fixed-fee delivery order contract to Sri International, a non-profit research institute, for non-clinical safety assessment of the drug candidate VK4-116 to support the treatment of severe pain disorders in human patients. This contract is part of the NCATS "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies"...
- HHSN271201700015IIndefinite Delivery Contract
- HHSN271201700015I-75N95020F00002Delivery Order
This is a $4,734,236.00 delivery order under the "CRO Support for NCATS In Vitro and In Vivo Toxicology Studies" IDIQ contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the Department of Health and Human Services. The award is for non-clinical safety assessment of NES100 to support an analgesia indication, with a period of performance from September 18, 2020 to April 17, 2021. The prime contractor is Battelle Memorial Institute, a nonprofit research and development organization. Battelle has subcontracted portions of the work to Inotiv, Inc., a for-profit contract research organization, to conduct bone marrow micronucleus analysis, toxicology studies, and other services. No set-aside was used for this award.
ContractNumber | Description | Subcontractor | Prime Award | Dollars Obligated | Updated At |
|---|---|---|---|---|---|
0000892549S | Inotiv, Inc. | Delivery Order HHSN271201700015I-75N95020F00002 | $50.0k | 4/3/24 | |
0000862242S | Amplifybio LLC | Delivery Order HHSN271201700015I-75N95020F00002 | $1.4m | 9/14/22 | |
0000857737S | Inotiv, Inc. | Delivery Order HHSN271201700015I-75N95020F00002 | $213.8k | 6/28/22 | |
0000825343S | Amplifybio LLC | Delivery Order HHSN271201700015I-75N95020F00002 | $465.2k | 5/19/21 |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00012 | Supplemental Agreement for work within scope | $0 | 3/24/25 | |
| P00011 | Supplemental Agreement for work within scope | $261.7k | 12/19/24 | |
| P00010 | Supplemental Agreement for work within scope | $357.0k | 4/29/24 | |
| P00009 | Supplemental Agreement for work within scope | $0 | 3/25/24 | |
| P00008 | Supplemental Agreement for work within scope | $286.1k | 3/20/23 |